AB Science announces that confirmatory Phase 3 study AB12005 with masitinib in first line pancreatic cancer with pain was successful
Paris, December 4, 2020, 8.30am AB Science announces that confirmatory Phase 3 study AB12005 with…
News
Seer Announces Pricing of Initial Public Offering
REDWOOD CITY, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) — Seer, Inc., a life sciences company…
Nicox Raises €15 million in Private Placement
Press Release Nicox Raises €15 million in Private Placement Strengthens financial position in advance…
Nicox Raises €15 million in Private Placement
Press Release Nicox Raises €15 million in Private Placement Strengthens financial position in advance…
ERYTECH Announces Conference Webcast to Discuss Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia to be Presented at the American Society of Hematology 2020 Annual Meeting
Webcast scheduled for Monday, December 7 at 4:00 pm CET/10:00 am ET LYON, France and…
Cambium Networks Corporation Announces Pricing of Secondary Offering
ROLLING MEADOWS, Ill., Dec. 03, 2020 (GLOBE NEWSWIRE) — Cambium Networks Corporation (Nasdaq: CMBM) (“Cambium”),…
BioCryst Announces FDA Approval of ORLADEYO™ (berotralstat), First Oral, Once-daily Therapy to Prevent Attacks in Hereditary Angioedema Patients
ORLADEYO™ (berotralstat) capsules ORLADEYO™ (berotralstat) capsules 150 mg —Significant and sustained reduction in HAE attacks—…
Sigilon Therapeutics Announces Pricing of Upsized Initial Public Offering
CAMBRIDGE, Mass., Dec. 03, 2020 (GLOBE NEWSWIRE) — Sigilon Therapeutics, Inc., a biotechnology company that…
Tauriga Sciences Inc. Fully Repays and Retires $88,333.00 Face Value 8.00% Convertible Debenture Issued on May 18, 2020
DECEMBER 2nd PR Hanukkah Special Gift Pack – Limited Edition (613 Packs) NEW YORK, NY,…
IN8bio announces first-in-human Phase 1 trial Update from The University of Kansas Cancer Center using INB-100, IN8bio’s Gamma Delta T-cell product candidate, at ASH 2020
NEW YORK, Dec. 03, 2020 (GLOBE NEWSWIRE) — IN8bio, Inc., a clinical-stage biotechnology company focused…